$3.87 0.24 (+6.61%)
11/25/2009 4:00 PM

GTx, Inc. (GTXI)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Featured Broker Partners